Salmoporc, lyophilisate for oral suspension for pigs
Salmoporc, lyophilisate for oral suspension for pigs
Authorised
- Salmonella enterica, subsp. enterica, serovar Typhimurium, Live
Product identification
Medicine name:
Salmoporc lyophilisate for oral suspension for pigs
Salmoporc, lyophilisate for oral suspension for pigs
Active substance:
- Salmonella enterica, subsp. enterica, serovar Typhimurium, Live
Target species:
-
Pig
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Salmonella enterica, subsp. enterica, serovar Typhimurium, Live8.00log10 colony forming unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral lyophilisate
Withdrawal period by route of administration:
-
Oral use
-
Pig
-
Meat and offal6week
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AE02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Cardboard box containing one 10 ml glass vial (type I) with rubber stoppers and aluminium crimp caps containing 200 doses (1 dose = 1 ml) of lyophilisate.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Similar biological application (Article 13(4) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva-Phylaxia Zrt.
- IDT Biologika GmbH
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10815/064/002
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0247/002
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Hungary
-
Ireland
-
Italy
-
Portugal
-
Romania
-
Slovakia
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: